Tirzepatide Weight Loss Treatment
RevIVeU is now offering Tirzepatide in our weight loss clinics. Tirzepatide is the active ingredient in Mounjaro, an FDA-approved medication for the treatment of diabetes. Tirzepatide is a peptide that is used off-label as a weekly diet injection until it is expected to receive FDA approval for weight loss later in 2023 or 2024. Phase III clinical studies demonstrate a 50% increase in bodyweight reduction in Tirzepatide vs. Semaglutide in a 52-week period, with similar side effects.
​
As the first to be a dual GIP/GLP-1 receptor co-agonist, Tirzepatide is stronger in controlling blood sugar levels and acts as a potent appetite suppressant by reducing feelings of hunger while increasing satiety even with reduced food intake.
​
Phase III studies seeking FDA approval for weight loss demonstrate a Tirzepatide 22.5% reduction in body weight compared to a 15% bodyweight reduction by that of semaglutide, with comparable side effects.
​
Patients can choose to receive Tirzepatide for only 1-week Tirzepatide 2.5mg as a trial for $130. Please be advised that Tirzepatide is dose-dependent upon the duration of use; meaning the longer you use it, the higher your dose may be, up to 15mg/week, the more effective Tirzepatide can be. However, most patients tend to stay at or below 10mg.
Tirzepatide Weekly Peptide Diet Shots
​
Tirzepatide weekly peptide diet injection should be kept in the refrigerator. Please be advised that Tirzepatide is dose-dependent upon the duration of use; meaning the longer you use it, the higher your dose will be with a max dose of 15 mg a week. Therefore, the price will increase as your dose is adjusted and increased by a licensed medical professional. If you miss 14 consecutive days, without an injection, you will need to restart at the starting dose (2.5 mg).
Step-Up Dosing for Tirzepatide Peptide Diet Shots
​
-
2.5 mg (7 days) $130
One week trial tirzepatide 2.5 mg: $130
​​​​
-
2.5 or 5 mg (30 days)
First month (4 weeks) tirzepatide 2.5 mg: $350
Second month (4 weeks) tirzepatide 5 mg: $450
​
-
7.5 or 10 mg (30 days)
Third month (4 weeks) tirzepatide 7.5 mg: $550
Fourth month (4 weeks) tirzepatide 10 mg: $650
​
-
12.5 or 15 mg (30 days)
Fifth month* (4 weeks) tirzepatide 12.5 mg: $750
Sixth month onward* (4 weeks) tirzepatide 15 mg: $850
*Not all patients will require this final increase to see desired results
Patients who have a history or diagnosis of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN II) are not eligible to receive semaglutide/tirzepatide